CBT
CABOT CORP
Key Financials
Operating Income
$621.0M
↑ 1.1%
Revenue
$3.7B
↓ 7.0%
Net Income
$331.0M
↓ 12.9%
Total Assets
$3.8B
↑ 2.1%
EPS (Diluted)
$6.02
↓ 10.4%
Gross Profit
$940.0M
↓ 2.1%
Cash & Equivalents
$258.0M
↑ 15.7%
Shareholders' Equity
$1.6B
↑ 8.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/14/2026 | View on SEC |
| 10-Q | 5/6/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
| 4 | 4/1/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 4 | 3/17/2026 | View on SEC |
| 4 | 3/17/2026 | View on SEC |
| 4 | 3/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CBT |
| Company Name | CABOT CORP |
| CIK | 16040 |
| Sector | Miscellaneous Chemical Products |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2890 |
| SIC Description | Miscellaneous Chemical Products |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | DE |
| Phone | 6173450100 |